Evidence map›Paper›PMID 36378672›Full record

ArticlePloS one2022

Multicenter validation of a machine learning phase space electro-mechanical pulse wave analysis to predict elevated left ventricular end diastolic pressure at the point-of-care.

Sanjeev P Bhavnani, Rola Khedraki, Travis J Cohoon, Frederick J Meine, Thomas D Stuckey, Thomas McMinn, Jeremiah P Depta, Brett Bennett, Thomas McGarry, William Carroll and 14 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 10 institutions in 1 country.

Sanjeev P BhavnaniDivision of Cardiovascular Medicine, Healthcare Innovation & Practice Transformation Laboratory, Scripps Clinic, San Diego, California, United States of America.ORCID 0000-0001-8161-9523
Rola KhedrakiDivision of Cardiology, Section Advanced Heart Failure, Scripps Clinic, San Diego, California, United States of America.
Travis J CohoonDivision of Cardiovascular Medicine, Healthcare Innovation & Practice Transformation Laboratory, Scripps Clinic, San Diego, California, United States of America.
Frederick J MeineNovant Health New Hanover Regional Medical Center, Wilmington, North Carolina, United States of America.
Thomas D StuckeyCone Health Heart and Vascular Center, Greensboro, North Carolina, United States of America.
Thomas McMinnAustin Heart, Austin, Texas, United States of America.
Jeremiah P DeptaRochester General Hospital, Rochester, New York, United States of America.ORCID 0000-0001-5095-2649
Brett BennettJackson Heart Clinic, Jackson, Mississippi, United States of America.
Thomas McGarryOklahoma Heart Hospital, Oklahoma City, Oklahoma, United States of America.
William CarrollCardiology Associates of North Mississippi, Tupelo, Mississippi, United States of America.
David SuhAtlanta Heart Specialists, Atlanta, Georgia, United States of America.
John A SteuterBryan Heart, Lincoln, Nebraska, United States of America.
Michael RobertsLexington Medical Center, West Columbia, South Carolina, United States of America.
Horace R GillinsCorVista Health, Inc., Washington, DC, United States of America.
Ian ShadforthCorVista Health, Inc., Washington, DC, United States of America.
Emmanuel LangeCorVista Health, Toronto, Ontario, Canada.
Abhinav DoomraCorVista Health, Toronto, Ontario, Canada.
Mohammad FirouziCorVista Health, Toronto, Ontario, Canada.
Farhad FathiehCorVista Health, Toronto, Ontario, Canada.
Timothy BurtonCorVista Health, Toronto, Ontario, Canada.ORCID 0000-0002-5492-9304
Ali KhosousiCorVista Health, Toronto, Ontario, Canada.
Shyam RamchandaniCorVista Health, Toronto, Ontario, Canada.
William E SandersCorVista Health, Inc., Washington, DC, United States of America.
Frank SmartLSU Health Science Center, New Orleans, Louisiana, United States of America.
Scripps Clinic · USBryan Health · USCone Health · USJackson Memorial Hospital · USLexington Medical Center · USLouisiana State University Health Sciences Center New Orleans · USNorth Mississippi Medical Center · USNovant Health · USOklahoma Heart Hospital · USRochester General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPhase space is a mechanical systems approach and large-scale data representation of an object in 3-dimensional space. Whether such techniques can be applied to predict left ventricular pressures non-invasively and at the point-of-care is unknown.

objectiveThis study prospectively validated a phase space machine-learned approach based on a novel electro-mechanical pulse wave method of data collection through orthogonal voltage gradient (OVG) and photoplethysmography (PPG) for the prediction of elevated left ventricular end diastolic pressure (LVEDP).

methodsConsecutive outpatients across 15 US-based healthcare centers with symptoms suggestive of coronary artery disease were enrolled at the time of elective cardiac catheterization and underwent OVG and PPG data acquisition immediately prior to angiography with signals paired with LVEDP (IDENTIFY; NCT #03864081). The primary objective was to validate a ML algorithm for prediction of elevated LVEDP using a definition of ≥25 mmHg (study cohort) and normal LVEDP ≤ 12 mmHg (control cohort), using AUC as the measure of diagnostic accuracy. Secondary objectives included performance of the ML predictor in a propensity matched cohort (age and gender) and performance for an elevated LVEDP across a spectrum of comparative LVEDP (<12 through 24 at 1 mmHg increments). Features were extracted from the OVG and PPG datasets and were analyzed using machine-learning approaches.

resultsThe study cohort consisted of 684 subjects stratified into three LVEDP categories, ≤12 mmHg (N = 258), LVEDP 13-24 mmHg (N = 347), and LVEDP ≥25 mmHg (N = 79). Testing of the ML predictor demonstrated an AUC of 0.81 (95% CI 0.76-0.86) for the prediction of an elevated LVEDP with a sensitivity of 82% and specificity of 68%, respectively. Among a propensity matched cohort (N = 79) the ML predictor demonstrated a similar result AUC 0.79 (95% CI: 0.72-0.8). Using a constant definition of elevated LVEDP and varying the lower threshold across LVEDP the ML predictor demonstrated and AUC ranging from 0.79-0.82.

conclusionThe phase space ML analysis provides a robust prediction for an elevated LVEDP at the point-of-care. These data suggest a potential role for an OVG and PPG derived electro-mechanical pulse wave strategy to determine if LVEDP is elevated in patients with symptoms suggestive of cardiac disease.

Indexed as

Ventricular Dysfunction, LeftBlood PressureHumansMachine LearningPoint-of-Care SystemsPulse Wave AnalysisStroke VolumeVentricular Function, LeftVentricular Pressure

Identifiers

PMID36378672
PMCPMC9665374
OpenAlexW4309070617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.